NCT06507865 Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
| NCT ID | NCT06507865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | W.L.Gore & Associates |
| Condition | Aneurysm |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2031-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-02-20 with a primary completion date of 2031-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.
Eligibility Criteria
Inclusion Criteria: Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements Patient has been or is intended to be treated with an eligible registry device Patient is age ≥ 18 years at time of informed consent signature. Exclusion Criteria: Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures. Patient with exclusion criteria required by local law. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06507865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06507865 currently recruiting?
Yes, NCT06507865 is actively recruiting participants. Contact the research team at gvalledi@wlgore.com for enrollment information.
Where is the NCT06507865 trial being conducted?
This trial is being conducted at Vienna, Austria, Copenhagen, Denmark, Dresden, Germany, Heidelberg, Germany and 11 additional locations.
Who is sponsoring the NCT06507865 clinical trial?
NCT06507865 is sponsored by W.L.Gore & Associates. The trial plans to enroll 200 participants.